Palogic Value Management’s Ares Capital ARCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.99M Buy
110,670
+99
+0.1% +$1.92K 0.84% 27
2025
Q4
$2.24M Buy
110,571
+619
+0.6% +$12.5K 0.93% 29
2025
Q3
$2.24M Buy
109,952
+1,828
+2% +$40.6K 0.9% 27
2025
Q2
$2.37M Buy
108,124
+1,359
+1% +$28.9K 0.97% 29
2025
Q1
$2.37M Buy
106,765
+2,200
+2% +$49.9K 1.02% 31
2024
Q4
$2.29M Buy
104,565
+4,970
+5% +$107K 0.87% 32
2024
Q3
$2.09M Buy
99,595
+3,074
+3% +$63.9K 0.71% 37
2024
Q2
$2.01M Sell
96,521
-21
-0% -$439 0.85% 35
2024
Q1
$2.01M Buy
96,542
+1,211
+1% +$24.5K 0.87% 37
2023
Q4
$1.91M Buy
95,331
+631
+0.7% +$12.3K 0.85% 42
2023
Q3
$1.84M Hold
94,700
0.87% 39
2023
Q2
$1.78M Buy
94,700
+372
+0.4% +$6.87K 0.84% 45
2023
Q1
$1.72M Buy
94,328
+5,895
+7% +$111K 0.84% 43
2022
Q4
$1.63M Buy
+88,433
New +$1.66M 0.85% 42

Other funds holding ARCC

Palogic Value Management's ARCC Position: Q1 2026 in Review

Palogic Value Management increased its Ares Capital (ARCC) stake by 0.09% in Q1 2026, buying an estimated $1.92K and bringing the position to 110,670 shares worth $1.99M. The position accounts for 0.84% of the portfolio, ranked #27.

Palogic Value Management first reported a position in ARCC in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.37M in Q2 2025. 806 funds tracked by Wall St. Rank hold ARCC as of Q1 2026.

  • Palogic Value Management held 110,670 shares of Ares Capital worth $1.99M as of Q1 2026.
  • Palogic Value Management bought 99 Ares Capital shares in Q1 2026, an estimated $1.92K.
  • Ares Capital made up 0.84% of Palogic Value Management's portfolio in Q1 2026, its #27 holding.
  • Palogic Value Management first reported a position in Ares Capital in Q4 2022 and has held it in 14 quarters since.
  • Palogic Value Management's Ares Capital position peaked at $2.37M in Q2 2025.
  • 806 funds tracked by Wall St. Rank held Ares Capital as of Q1 2026.

Based on Palogic Value Management's 13F filing for Q1 2026, filed 15 May 2026.